CLINICO-PHARMACOLOGICAL ASPECTS OF OVARIAN-MENSTRUAL CYCLE SUPPORT. Review
Article PDF (Українська)

Keywords

Ovarian-menstrual cycle, pharmacological support

Abstract views: 18
PDF Downloads: 9

How to Cite

Turchak , D., & Khaitovych, M. (2022). CLINICO-PHARMACOLOGICAL ASPECTS OF OVARIAN-MENSTRUAL CYCLE SUPPORT. Review . Medical Science of Ukraine (MSU), 18(1), 84-96. https://doi.org/10.32345/2664-4738.1.2022.11

Abstract

Relevance. It is known that 12.5% of women suffer from infertility. Correction of menstrual disorders is an important way to maintain a woman's reproductive health.

Objective is to consider current data on the physiology, etiopathogenesis and pharmacotherapy of women with ovarian-menstrual disorders.

Methods. Analysis of the data presented in PubMed, by keywords "ovarian-menstrual cycle", "pharmacological support".

Results. Modern data on physiology, humoral regulation of the ovarian-menstrual cycle are presented. The role of positive and negative feedback between estradiol and progesterone levels and the activity of anterior pituitary gonadotropic hormones and insulin regulatory pathways is emphasized. The main changes of the central nervous system and behavioral features depending on the phase of the menstrual cycle are described. The directions of pharmacological support and stimulation of ovulation are described. The mechanisms of action and indications for the use of oral hypoglycemic and gonadotropic drugs, the benefits and place of each in the maintenance and stimulation of the ovarian-menstrual cycle are presented. Metformin is effective in clomiphene-resistant women and may be combined with clomiphene, particularly in the treatment of polycystic ovary syndrome (PCOS). Sitagliptin improves ovulation in PCOS, is more effective in combination with metformin. Gonadotropins stimulate the ovaries, promoting the production and maturation of eggs, progesterone prepares the inner layer of the uterus to fix the embryo and helps to bear fruit. They are mainly used in women with PCOS in whom other drugs are ineffective.Some results of pharmacogenetic researches, efficiency, in particular, use of follicle-stimulating hormone depending on genetic polymorphisms of its receptor are noted.

Conclusions. In modern conditions, the use of pharmacological agents is an important area of support and stimulation of the ovarian-menstrual cycle to improve female reproductive function.

https://doi.org/10.32345/2664-4738.1.2022.11
Article PDF (Українська)

References

Datta J, Palmer MJ, Tanton C, Gibson LJ, Jones KG, Macdowall W, Glasier A, Sonnenberg P, Field N, Mercer CH, Johnson AM, Wellings K. Prevalence of infertility and help seeking among 15 000 women and men. Hum Reprod. 2016; 31(9): 2108-2118. DOI: 10.1093/humrep/dew123.

View at:

Publisher Site: https://academic.oup.com/humrep/article/31/9/2108/2913864?login=false

PubMed: https://pubmed.ncbi.nlm.nih.gov/27365525/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991655/

Thiyagarajan D, Basit H, Jeanmonod R. Physiology, Menstrual Cycle. StatPearls [Internet]. 2021.

View at:

PubMed Central: https://www.ncbi.nlm.nih.gov/books/NBK500020

Giudice LC. Review Open Access Application of functional genomics to primate endometrium: insights into biological processes. Reproductive Biology and Endocrinology. 2006; 4(Suppl 1):S4. DOI: 10.1186/1477-7827-4-S1-S4.

View at:

Publisher Site: https://rbej.biomedcentral.com/articles/10.1186/1477-7827-4-S1-S4

PubMed: https://pubmed.ncbi.nlm.nih.gov/17118168/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1775064/

Bois FY, Golbamaki-Bakhtyari N, Kovarich S, Tebby C, Gabb HA, Lemazurier E. High-Throughput Analysis of Ovarian Cycle Disruption by Mixtures of Aromatase Inhibitors. Environmental Health Perspectives. 2017;125(7): 077012. DOI: 10.1289/EHP742.

View at:

Publisher Site: https://ehp.niehs.nih.gov/doi/10.1289/EHP742

PubMed: https://pubmed.ncbi.nlm.nih.gov/28886606/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744692/

Jacobson MH., Howardsa PP, Darrowa LA, Meadowsd JW, Kesnerd JS, Spencere JB, Terrell ML, Marcus M. Thyroid hormones and menstrual cycle function in a longitudinal cohort of premenopausal women. Paediatr Perinat Epidemiol. 2018 May; 32(3): 225-234. DOI: 10.1111/ppe.12462.

View at:

Publisher Site: https://onlinelibrary.wiley.com/doi/10.1111/ppe.12462

PubMed: https://pubmed.ncbi.nlm.nih.gov/29517803/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980701/

Dupont J, Scaramuzzi RJ. Insulin signalling and glucose transport in the ovary and ovarian function during the ovarian cycle. Biochem. J. 2016; 473(11): 1483-1501. DOI: 10.1042/BCJ20160124

View at:

Publisher Site: https://portlandpress.com/biochemj/article-abstract/473/11/1483/49189/Insulin-signalling-and-glucose-transport-in-the?redirectedFrom=fulltext

PubMed: https://pubmed.ncbi.nlm.nih.gov/27234585/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888492/

Joshi S, Jaideep K. Neurosteroid regulation of GABAa receptors: a role in catamenial epilepsy. Brain Res. 2019; 1703: 31-40. DOI: 10.1016/j.brainres.2018.02.031.

View at:

Publisher Site: https://www.sciencedirect.com/science/article/abs/pii/S000689931830101X?via%3Dihub

PubMed: https://pubmed.ncbi.nlm.nih.gov/29481795/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107446/

Dubol M, Epperson CN, Sacher J, Pletzer B, Derntl B, Lanzenberger R, Sundström-Poromaa I, Comasco E. Neuroimaging the menstrual cycle: A multimodal systematic review. Front Neuroendocrinol. 2021;60:100878. DOI: 10.1016/j.yfrne.2020.100878.

View at:

Publisher Site: https://www.sciencedirect.com/science/article/pii/S0091302220300698?via%3Dihub

PubMed: https://pubmed.ncbi.nlm.nih.gov/33098847/

Kiesner J. Evolution, the Menstrual Cycle, and Theoretical Overreach. Perspect Psychol Sci. 2020; 15(4): 1113-1130. DOI:10.1177/1745691620906440.

View at:

Publisher Site: https://journals.sagepub.com/doi/10.1177/1745691620906440

PubMed: https://pubmed.ncbi.nlm.nih.gov/32539582/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334061/

Diekhof EK, Korf S, Ott F, Schädlich C, Holtfrerich SKC. Avoidance Learning Across the Menstrual Cycle: A Conceptual Replication. Front. Endocrinol. (Lausanne). 2020; 11:231. DOI: 10.3389/fendo.2020.00231.

View at:

Publisher Site: https://www.frontiersin.org/articles/10.3389/fendo.2020.00231/full

PubMed: https://pubmed.ncbi.nlm.nih.gov/32390943/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193994/

Brown AMC, Gervais NJ. Role of Ovarian Hormones in the Modulation of Sleep in Females Across the Adult Lifespan. Endocrinology. 2020; 161(9): bqaa128. DOI: 10.1210/endocr/bqaa128: 10.1210/endocr/bqaa128.

View at:

Publisher Site: https://academic.oup.com/endo/article/161/9/bqaa128/5879359

Romans SE, Kreindler D, Einstein G, Laredo S, Petrovic MJ, Stanley J. Sleep quality and the menstrual cycle. Sleep Med. 2015; 16(4):489-95. DOI: 10.1016/j.sleep.2014.12.001.

View at:

Publisher Site: https://www.sciencedirect.com/science/article/abs/pii/S1389945714004900?via%3Dihub

PubMed: https://pubmed.ncbi.nlm.nih.gov/25747332/

Bayer J, Schultz H, Gamer M, Sommer T. Menstrual-cycle dependent fluctuations in ovarian hormones affect emotional memory. Neurobiol Learn Mem. 2014;110:55-63. DOI: 10.1016/j.nlm.2014.01.017.

View at:

Publisher Site: https://www.sciencedirect.com/science/article/abs/pii/S1074742714000252?via%3Dihub

PubMed: https://pubmed.ncbi.nlm.nih.gov/24492058/

Joyce K, Good KP, Tibbo P, Brown J, Stewart SH. Addictive behaviors across the menstrual cycle: a systematic review. Arch Womens Ment Health. 2021;24(4):529-542. DOI: 10.1007/s00737-020-01094-0.

View at:

Publisher Site: https://link.springer.com/article/10.1007/s00737-020-01094-0

PubMed: https://pubmed.ncbi.nlm.nih.gov/33404701/

Thomas SG, Czoty PW. Effect of menstrual cycle on ethanol drinking in rhesus monkeys. Drug Alcohol Depend. 2019; 194: 205-209. DOI: 10.1016/j.drugalcdep.2018.11.001.

View at:

Publisher Site: https://www.sciencedirect.com/science/article/abs/pii/S0376871618307026?via%3Dihub

PubMed: https://pubmed.ncbi.nlm.nih.gov/30453105/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312462/

Dirk KL, Belfry GR, Heath M. Exercise and Executive Function during Follicular and Luteal Menstrual Cycle Phases. Med Sci Sports Exerc. 2020;52(4):919-927. DOI: 10.1249/MSS.0000000000002192.

View at:

Publisher Site: https://journals.lww.com/acsm-msse/Fulltext/2020/04000/Exercise_and_Executive_Function_during_Follicular.18.aspx

PubMed: https://pubmed.ncbi.nlm.nih.gov/31652244/

Sims ST, Heather AK. Myths and Methodologies: Reducing scientific design ambiguity in studies comparing sexes and/or menstrual cycle phases. Experimental Physiology. 2018;103(10):1309-1317. DOI: 10.1113/EP086797.

View at:

Publisher Site: https://physoc.onlinelibrary.wiley.com/doi/full/10.1113/EP086797

PubMed: https://pubmed.ncbi.nlm.nih.gov/30051938/

Findlay RJ, Macrae EHR, Whyte Y, Easton C, Forrest LJ (née Whyte). How the menstrual cycle and menstruation affect sporting performance: experiences and perceptions of elite female rugby players. Br J Sports Med. 2020;54(18):1108-1113. DOI: 10.1136/bjsports-2019-101486.

View at:

Publisher Site: https://bjsm.bmj.com/content/54/18/1108

PubMed: https://pubmed.ncbi.nlm.nih.gov/32349965/

Schulze J, Suominen T, Bergström H, Ericsson M, Bergman LB, Ekström L. Urinary steroid profile in relation to the menstrual cycle. Drug Test Anal. 2021;13:550-557. DOI: 10.1002/dta.2960.

View at:

Publisher Site: https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/full/10.1002/dta.2960?af=R

Broestl L, Worden K, Moreno AJ, Davis EJ, Wang D, Garay B, SinghT, VerretL, Palop JJ, Dubal DB. Ovarian Cycle Stages Modulate Alzheimer Related Cognitive and Brain Network Alterations in Female Mice. Disorders of the Nervous System. 2018; 5(6):ENEURO.0132-17.2018. DOI: 10.1523/ENEURO.0132-17.2018.

View at:

Publisher Site: https://www.eneuro.org/content/5/6/ENEURO.0132-17.2018

PubMed: https://pubmed.ncbi.nlm.nih.gov/30627643/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325547/

Albert K, Pruessnerd J, Newhousea P. Estradiol Levels Modulate Brain Activity and Negative Responses to Psychosocial Stress across the Menstrual Cycle. Psychoneuroendocrinology. 2015; 59: 14-24. DOI: 10.1016/j.psyneuen.2015.04.022.

View at:

Publisher Site: https://www.sciencedirect.com/science/article/abs/pii/S0306453015001730?via%3Dihub

PubMed: https://pubmed.ncbi.nlm.nih.gov/26123902/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492530/

Frokjaer VG. Pharmacological sex hormone manipulation as a risk model for depression. J Neurosci Res. 2020;98(7):1283-1292. DOI: 10.1002/jnr.24632.

View at:

Publisher Site: https://onlinelibrary.wiley.com/doi/10.1002/jnr.24632

PubMed: https://pubmed.ncbi.nlm.nih.gov/32399989/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383584/

Peters JR, Eisenlohr-Moul TA. Ovarian Hormones as a Source of Fluctuating Biological Vulnerability in Borderline Personality Disorder. Curr Psychiatry Rep. 2019; 21(11): 109. DOI:10.1007/s11920-019-1096-y.

View at:

Publisher Site: https://link.springer.com/article/10.1007/s11920-019-1096-y

PubMed: https://pubmed.ncbi.nlm.nih.gov/31624929/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047501/

Peters JR, Owens SA, Schmalenberger KM, Eisenlohr-Moul TA. Differential Effects of the Menstrual Cycle on Reactive and Proactive Aggression in Borderline Personality Disorder. Aggress Behav. 2020; 46(2): 151-161. DOI:10.1002/ab.21877.

View at:

Publisher Site: https://onlinelibrary.wiley.com/doi/abs/10.1002/ab.21877

Hildebrandt BA, Racine SE, Keel PK, Burt A, Neale M, Boker S, Sisk CL, Klump KL. The Effects of Ovarian Hormones and Emotional Eating on Changes in Weight Preoccupation Across the Menstrual Cycle. Int J Eat Disord. 2015; 48(5): 477-486. DOI:10.1002/eat.22326.

View at:

Publisher Site: https://onlinelibrary.wiley.com/doi/10.1002/eat.22326

PubMed: https://pubmed.ncbi.nlm.nih.gov/24965609/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4277499/

Vovk IB. [ Features of the use of combined oral contraceptives with contraceptive and treatment-prophylactic purposes]. Medical aspects of a healthy woman. 2018; 5(118):24-31. [in Ukrainian]

View at:

Publisher Site: https://mazg.com.ua/ua/archive/2018/5%28118%29/pages-24-31/osoblivosti-zastosuvannya-kombinovanih-oralnih-kontraceptiviv-z-kontraceptivnoyu-ta-likuvalno-profilaktichnoyu-metoyu-

Brents LK. Marijuana, the Endocannabinoid System and the Female Reproductive System. Yale J Biol Med. 2016; 89(2): 175-191.

View at:

PubMed: https://pubmed.ncbi.nlm.nih.gov/27354844

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918871/

Soldin OP, Mattison DR. Sex Differences in Pharmacokinetics and Pharmacodynamics. Clin Pharmacokinet. 2009; 48(3): 143-157. DOI:10.2165/00003088-200948030-00001.

View at:

Publisher Site: https://link.springer.com/article/10.2165/00003088-200948030-00001

PubMed: https://pubmed.ncbi.nlm.nih.gov/19385708/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3644551/

Evans MB, Nobles CJ, Kim K, Hill MJ, DeCherney AH, Silver RM, Mumford SL, Sjaarda LA, Perkins NJ, Schisterman EF. Low-dose aspirin in reproductive health: effects on menstrual cycle characteristics. Fertil Steril. 2020; 114(6): 1263-1270. DOI: 10.1016/j.fertnstert.2020.06.022.

View at:

Publisher Site: https://www.fertstert.org/article/S0015-0282(20)30594-X/fulltext

PubMed: https://pubmed.ncbi.nlm.nih.gov/32896390/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722096/

Daneshjou D, Mehranjani MS, Modarres SZ, Shariatzadeh MA. Sitagliptin/Metformin: A New Medical Treatment in Polycystic Ovary Syndrome. Trends Endocrinol Metab. 2020;31(12):890-892. DOI: 10.1016/j.tem.2020.09.002.

View at:

Publisher Site: https://www.cell.com/trends/endocrinology-metabolism/fulltext/S1043-2760(20)30175-2?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1043276020301752%3Fshowall%3Dtrue

PubMed: https://pubmed.ncbi.nlm.nih.gov/33059962/

Zaychenko GV. [The role of inositol in the management of polycystic ovary syndrome depending on a woman's reproductive plans]. 2021. [Internet]. [in Ukrainian]

View at:

Publisher Site: https://health-ua.com/article/66398-rol-nozitolv-umenedzhment-sindromu-polkstoznih-yachnikv-zalezhno-vd-reprodu

Hampson E. A brief guide to the menstrual cycle and oral contraceptive use for researchers in behavioral endocrinology. Horm Behav. 2020;119:104655. DOI: 10.1016/j.yhbeh.2019.104655.

View at:

Publisher Site: https://www.sciencedirect.com/science/article/abs/pii/S0018506X19304623?via%3Dihub

PubMed: https://pubmed.ncbi.nlm.nih.gov/31843564/

Fatemi HM , Blockeel C, Devroey P. Ovarian stimulation: today and tomorrow. Curr Pharm Biotechnol. 2012;13(3):392-7. DOI: 10.2174/138920112799362007.

View at:

Publisher Site: http://www.eurekaselect.com/article/21463

PubMed: https://pubmed.ncbi.nlm.nih.gov/21657998/

Raju GAR, Chavan R, Deenadayal M, Gunasheela D, Gutgutia R, Haripriya G, Govindarajan M, Patel NH, Patki AS. Luteinizing hormone and follicle stimulating hormone synergy: A review of role in controlled ovarian hyper-stimulation. J Hum Reprod Sci. 2013;6(4):227-34. DOI: 10.4103/0974-1208.126285.

View at:

Publisher Site: https://www.jhrsonline.org/article.asp?issn=0974-1208;year=2013;volume=6;issue=4;spage=227;epage=234;aulast=Rama

PubMed: https://pubmed.ncbi.nlm.nih.gov/24672160/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963304/

Wu N-Y, Huang H-S, Chao TH, Chou HM, Fang C, Qin C-Z, Lin C-Y, Chu T-Y, Zhou HH. Progesterone Prevents High-Grade Serous Ovarian Cancer by Inducing Necroptosis of p53-Defective Fallopian Tube Epithelial Cells. Cell Reports. 2017; 18(11): 2557-2565. DOI: 10.1016/j.celrep.2017.02.049.

View at:

Publisher Site: https://www.cell.com/cell-reports/fulltext/S2211-1247(17)30247-4?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2211124717302474%3Fshowall%3Dtrue

PubMed: https://pubmed.ncbi.nlm.nih.gov/28297660/

PubMed Central:

Kuang Y, Chen Q, Hong Q, Lyu Q, Ai A, Fu Y, Shoham Z. Double stimulations during the follicular and luteal phases of poor responders in IVF/ICSI programmes (Shanghai protocol). Reprod Biomed Online. 2014;29(6):684-91. DOI: 10.1016/j.rbmo.2014.08.009.

View at:

Publisher Site: https://www.rbmojournal.com/article/S1472-6483(14)00485-4/fulltext

PubMed: https://pubmed.ncbi.nlm.nih.gov/25444501/

Hsueh AJW, Kawamura K, Cheng Y, Fauser BCJ. Intraovarian control of early folliculogenesis. Endocr Rev. 2015 Feb;36(1):1-24. DOI: 10.1210/er.2014-1020.

View at:

Publisher Site: https://academic.oup.com/edrv/article/36/1/1/2354672?login=false

PubMed: https://pubmed.ncbi.nlm.nih.gov/25202833/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309737/

Lledo B, Llácer J, Ortiz JA, Martinez B, Morales R, Bernabeu R. A pharmacogenetic approach to improve low ovarian response: The role of CAG repeats length in the androgen receptor gene. Eur J Obstet Gynecol Reprod Biol. 2018; 227:41-45. DOI: 10.1016/j.ejogrb.2018.06.001.

View at:

Publisher Site: https://www.ejog.org/article/S0301-2115(18)30277-X/fulltext

PubMed: https://pubmed.ncbi.nlm.nih.gov/29886316/

Lledo B, Ortiz JA, Llacer J, Bernabeu R. Pharmacogenetics of ovarian response. Pharmacogenomics. 2014;15(6):885-93. DOI: 10.2217/pgs.14.49.

View at:

Publisher Site: https://www.futuremedicine.com/doi/10.2217/pgs.14.49

PubMed: https://pubmed.ncbi.nlm.nih.gov/24897293/

Conforti A, Vaiarelli A, Cimadomo D, Bagnulo F, Peluso S, Carbone L, Rella FD, Placido GD, Ubaldi FM, Huhtaniemi I, Alviggi C. Pharmacogenetics of FSH Action in the Female. Front Endocrinol (Lausanne). 2019;10:398. DOI: 10.3389/fendo.2019.00398.

View at:

Publisher Site: https://www.frontiersin.org/articles/10.3389/fendo.2019.00398/full

PubMed: https://pubmed.ncbi.nlm.nih.gov/31293516/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606727/

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.